논문 검색
-
Hsa_circ_0002111 implicates KTC-1 cell motility and modulates migration and invasion via miR-432-5p/CDKN2B axis.
Hsa_circ_0002111 is highly expressed in papillary thyroid carcinoma (PTC). We therefore investigated its role and underlying mechanism in promoting PTC progression. Q-RT-PCR, dual-luciferase reporter assays, AGO2-RIP, CCK-8, colony formatio…
FULLTEXT: AGO2 -
Molecular Dynamics Simulation-Assisted siRNA Design for Dual-Ubiquitinated SKP2 Silencing via Ago2 Anchoring in Breast Cancer.
S-phase kinase-associated protein 2 (SKP2) functions as a dual-ubiquitin modulator in breast cancer progression by orchestrating two distinct ubiquitination process. Through Ub-K48-linked degradation, SKP2 facilitates proteasomal turnover o…
FULLTEXT: AGO2 -
Small Activating RNAs: Delivery and Therapeutic Applications in Disease Treatment.
TL;DREffective in vivo delivery of saRNAs is achieved using various delivery systems, including lipid nanoparticles, aptamers, dendrimers, and lipopolyplexes, enabling the guide strand to direct AGO2 to the nucleus and activa…
FULLTEXT: AGO2 -
Impact of coding and non-coding SNPs in the FZD8 gene on structural and functional alterations associated with tumorigenesis: A multi-faceted computational approach.
TL;DRThese computationally prioritized high risk SNPs of FZD8 can be investigated in population based genetic studies and may serve as potential targets for future drug development against FZD8-associated diseases.
FULLTEXT: AGO2 -
NSUN2 promoted tumor growth and metastatic via mC-regulation of YAP through ALYREF/YBX1 axis in NSCLC.
NSUN2-dependent RNA mC methylation is essential for RNA stability, cellular metabolism, and intracellular transport. Aberrant YAP expression is closely associated with tumorigenesis and progression in human cancers. However, the molecular m…
FULLTEXT: AGO2 -
CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AML18 trial.
We compared daunorubicin/cytarabine plus fractionated gemtuzumab ozogamicin (DAGO2) with CPX-351 (CPX; 1:2 randomization) in 439 patients with acute myeloid leukemia (AML) aged ≥60 years (median age, 68 years) without known adverse-risk cyt…
FULLTEXT: AGO2 -
ULK1-driven autophagy modulation alters tumor-promoting pathways in triple-negative breast cancer.
Triple-negative breast cancer (TNBC) is an aggressive subtype with limited targeted therapies and poor prognosis. Unc-51-like kinase 1 (ULK1), a central regulator of autophagy, has emerged as a potential therapeutic node in cancer but remai…
FULLTEXT: AGO2 -
tRF-Ser-TGA-011 impedes gastric cancer progression by targeting the MAP3K13/JNK signaling cascade.
[BACKGROUND] Early-stage gastric cancer (GC) is often asymptomatic, leading to frequent late-stage diagnoses. There is a critical need for non-invasive biomarkers to improve early detection and preoperative risk assessment. Although tRNA-de…
FULLTEXT: AGO2 -
Designing & screening of siRNA molecules for silencing the impact of the VEGF gene in cancer cells.
Cancer is a complex disease characterized by uncontrolled cell proliferation and metastasis, with breast cancer remaining a leading cause of mortality among women worldwide. Hypoxia-inducible factor (HIF) and vascular endothelial growth fac…
FULLTEXT: AGO2 -
Integrated Bioinformatics and Experimental Analysis of Argonaute Family Members in Pancreatic Adenocarcinoma.
[BACKGROUND/AIM] Pancreatic adenocarcinoma (PAAD) is an aggressive cancer type with high mortality rates. The Argonaute (AGO) gene/protein family is an evolutionary conserved family, which is responsible for post-transcriptional regulation …
FULLTEXT: AGO2 -
POFUT2 Mediated Fucosylation of JUP Enhances VEGFA Expression to Promote Angiogenesis in Colorectal Cancer.
Colorectal cancer (CRC) ranks as the third most common cancer globally and is characterized by a poor prognosis. Abnormal glycosylation, a hallmark of cancer development, influences multiple signaling pathways and contributes to CRC progres…
FULLTEXT: AGO2 -
Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML.
Despite the use of FMS-like tyrosine kinase 3 (FLT3) inhibitors, outcomes for patients with FLT3-mutated (FLT3mut) acute myeloid leukemia (AML) remain suboptimal because of high rates of relapse. We evaluated the safety and efficacy of the …
FULLTEXT: AGO2 -
CircZFAND6 suppresses gastric cancer metastasis and reduces resistance to TKI therapy.
[BACKGROUND] Peritoneal metastasis, the most common mode of dissemination in gastric cancer (GC), is characterized by resistance to treatment and a poor prognosis. Accumulating evidence indicates that circular RNAs (circRNAs) play a signifi…
FULLTEXT: AGO2 -
CircATP2C1 Drives Prostate Cancer Progression Through miR-654-3p-Mediated SLC7A11 Upregulation and Ferroptosis Suppression.
: Prostate cancer, an epithelial malignancy occurring in the prostate, is the most common malignant tumor of the male genitourinary system and has a low survival rate in advanced prostate cancer after metastasis. It is urgent to explore nov…
FULLTEXT: AGO2 -
Non-Canonical Compartmentalization of DROSHA Protein at the Golgi Apparatus: miRNA Biogenesis-Independent Functionality in Human Cancer Cells of Diverse Tissue Origin.
DROSHA protein is widely known for its essential role in the microRNA (miRNA/miR) biogenesis pathway where, together with its co-factor DGCR8, it forms the "Microprocessor" complex and catalyzes the primary miRNA (pri-miRNA) processing in t…
FULLTEXT: AGO2 -
Identification of tRF-29-79MP9P9NH525 as a biomarker and tumor suppressor of gastric cancer via regulating KIF14/AKT pathway.
Gastric cancer (GC) is one of the most common malignancies with a poor prognosis. The development of novel biomarkers is of utmost importance to screen patients with GC. Molecular mechanism study of GC may provide a research basis for the d…
FULLTEXT: AGO2 -
Identification of Common miRNAs Differentially Expressed in Periodontitis and Pancreatic Cancer.
[BACKGROUND/AIM] Periodontitis is a prevalent multifactorial, oral infectious disease and is considered a high-risk factor for pancreatic cancer. Nevertheless, there is limited understanding of the underlying epigenetic mechanisms governing…
FULLTEXT: AGO2 -
The functional roles of deoxyelephantopin potential target circTNPO3 in regulating pancreatic cancer malignant phenotype and gemcitabine chemoresistance via miR-188-5p/CDCA3/TRAF2-mediated remodeling of NF-κB signaling pathway.
[BACKGROUND] Pancreatic cancer (PC) has been one of the most severe digestive system malignant tumor with poor prognosis that threatens human health. Chemotherapy is essential for patients with advanced PC, but unfortunately the curative ef…
FULLTEXT: AGO2 -
miR-210 Expression Is Strongly Hypoxia-Induced in Anaplastic Thyroid Cancer Cell Lines and Is Associated with Extracellular Vesicles and Argonaute-2.
Hypoxia, or low oxygen tension, is frequently found in highly proliferative solid tumors such as anaplastic thyroid carcinoma (ATC) and is believed to promote resistance to chemotherapy and radiation. Identifying hypoxic cells for targeted …
FULLTEXT: AGO2 -
lncRNA EGFEM1P Drives the Progression of Papillary Thyroid Cancer by Regulating miR-6867-5p/CHI3L1 Axis.
Long noncoding RNA (lncRNA), a subgroup of noncoding RNA with > 200 nt, plays critical roles in cancer progression. Here, we aimed to explore the detailed biological function of lncRNA EGFEM1P during papillary thyroid cancer (PTC) progressi…
FULLTEXT: AGO2